Restore Medical gets VC funds for snore therapy:
This article was originally published in Clinica
Executive Summary
Restore Medical, of St Paul, Minnesota, has raised $26.5m in a series C financing led by Bessemer Venture Partners. The company said the proceeds would help it continue commercialisation of the Pillar system, a minimally invasive treatment for snoring. It also plans to expand its business in sleep and breathing technology. The Pillar system obtained FDA approval to treat snoring in December 2002, and a 510(k) application has been submitted for its use in treating patients with obstructive sleep apnoea. It is a small woven polyester device that is implanted under local anaesthesia in a patient's soft palate.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.